Immunotherapy for B-cell lymphoma: current status and prospective advances
about
Inhibition of STAT3 activity re-activates anti-tumor immunity but fails to restore the immunogenicity of tumor cells in a B-cell lymphoma modelCancer immunotherapy and breaking immune tolerance: new approaches to an old challenge.Three steps to breaking immune tolerance to lymphoma: a microparticle approach.B Cell in Autoimmune Diseases.Successes, failures and new perspectives of idiotypic vaccination for B-cell non-Hodgkin lymphomas.Update on obinutuzumab in the treatment of B-cell malignancies.The promise of the anti-idiotype concept.Novel B7-H4-mediated crosstalk between human non-Hodgkin lymphoma cells and tumor-associated macrophages leads to immune evasion via secretion of IL-6 and IL-10.
P2860
Q34028436-4ABB2E25-AE70-47E8-AA5E-6B11523C747DQ34859794-87AAB549-579D-4088-BFCB-A42684F25F64Q35328686-15C7BCC8-6DC8-467D-9598-606B701AC0E0Q36954468-22BF6D4C-DBFA-4FF8-8D38-98BFAF5A41EFQ37505384-979B809E-D4C5-46E3-A165-14ED53FA1B2EQ38246230-E8AE5455-C704-46D9-BE61-D56E2BCC7FA6Q42419120-10905FBD-ADC2-4B82-B8D9-FC9FFAA2E978Q48819240-631CECC0-3131-4CF1-8741-788B3CB79F80
P2860
Immunotherapy for B-cell lymphoma: current status and prospective advances
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Immunotherapy for B-cell lymphoma: current status and prospective advances
@en
type
label
Immunotherapy for B-cell lymphoma: current status and prospective advances
@en
prefLabel
Immunotherapy for B-cell lymphoma: current status and prospective advances
@en
P2860
P356
P1476
Immunotherapy for B-cell lymphoma: current status and prospective advances
@en
P2093
Nurit Hollander
P2860
P356
10.3389/FIMMU.2012.00003
P577
2012-01-24T00:00:00Z